India has relaxed export curbs on paracetamol formulations and made it free for exports with immediate effect, as reported Business Line on Friday.
However, according to a notification by the Directorate General of Foreign Trade (DGFT), export of paracetamol active pharmaceutical ingredients (APIs) will remain restricted.
On March 3, the government had restricted the export of paracetamol formulations and APIs, fearing a shortage in the country following the COVID-19 spread.
On April 6, the DGFT eased restrictions on export of 24 APIs, mostly vitamins and hormonal medicines, but while the prohibition on export of hydroxychloroquine continues, the government has decided to export some quantities to 55 countries both on commercial basis and as grants.
To read more NewsPoints articles, click here.